News

QLT has announced the settlement of its litigation with the General Hospital, doing business as Massachusetts General Hospital (MGH). Under the terms of the settlement agreement, QLT will

Nanosphere has received 510(k) clearance from the FDA to update its package insert for its Verigene Respiratory Virus Nucleic Acid Test on Verigene SP System (RVNATSP). It is

Catalent Pharma Solutions (Catalent) has appointed Paul Burns as a new vice president of global sales. In this newly created role, Mr. Burns will be responsible for developing

American Scientific Resources (ASR) has opened a regional marketing and production management office in Shanghai, China. The company has been able to secure a location abroad, providing an

LFB Biotechnologies’ (LFB) recombinant anti-CD20 monoclonal antibody received orphan drug status for the treatment of chronic lymphocytic leukemia (CLL). The company received the approval from the EMEA’s Committee

GW Pharmaceuticals (GW) has completed patient enrollment in its Sativex Phase II/III cancer pain trial. The study is being carried out in collaboration with Otsuka Pharmaceutical (Otsuka), GW’s

Gen-Probe Incorporated (Gen-Probe) has announced that Prodesse’s ProParaflu+ assay has received US Food & Drug (FDA) approval. This assay is a molecular test that detects and differentiates parainfluenza

Æterna Zentaris has announced positive efficacy data from a Phase 2 study with its targeted cytotoxic peptide conjugate, AEZS-108 (formerly AN-152), in patients with advanced or recurrent endometrial

Simulations Plus has released GastroPlus Version 6.1, the latest version of its software used by pharmaceutical research scientists for simulation of oral absorption, intravenous dosing, pharmacokinetics, and pharmacodynamics.